Body's natural defence carries early warning system for recurring cancers

November 18, 2013

(Medical Xpress)—Scientists at the University of Leeds have found that the immune system's behaviour can act as an early warning alarm that detects cancer recurrence, and this could offer a chance for pre-emptive treatment.

When cancers go into remission, small groups of cells sometimes hide away, lying dormant until they reawaken and grow once more.

Oncologists at the University, Leeds Teaching Hospitals and The Institute of Cancer Research, London, working with colleagues at the Mayo Clinic in the US, found that this reawakening of the cancer after treatment occurs because the disease has evolved to evade the immune system which – until that point – had kept it under control.

The Cancer Research UK-funded study, in mice, involved researchers looking for early signs of the immune response 'kicking in' indicating that the cancer was once more active. This allowed them to predict accurately when the cancer was about to return.

Professor Alan Melcher, a Cancer Research UK senior clinical research fellow at the University of Leeds, said: "The ability to predict when a patient's cancer will come back would be an invaluable tool in treating the disease, allowing doctors to treat the recurrence rapidly and effectively before it takes hold. But we now need to find a way of using this knowledge to develop a test for patients whose cancer could take several years to reappear."

Intriguingly, the scientists found they could deliberately reawaken the cancer cells, before they have evolved the ability to evade the , and then use the mice's own defences to track down and kill the remaining cancer cells. In the study, this approach cured up to 100 per cent of the mice that would otherwise have relapsed.

Researchers believe that this could possibly lead to a change in how cancers are treated, by waking them back up before they're ready to beat . But this would need highly effective monitoring and failsafe treatments, which are not yet widely available for most cancers in a clinic. Current approaches are limited to having to wait until the cancer reappears, by which time it has sometimes evolved to evade common treatments.

Professor Kevin Harrington, Joint Head of the Division of Radiotherapy and Imaging at The Institute of Cancer Research, London, and Honorary Consultant Clinical Oncologist at The Royal Marsden NHS Foundation Trust, said: "This approach to reawakening the cancer deliberately may seem controversial, but a similar approach is already used in some patients with thyroid cancers. They are given thyroid stimulating hormone to reveal any hidden tumours so that they can be treated with further radio-iodide therapy.

"This illustrates the potential of a general clinical approach to flushing out any remaining cancer cells and treating them while they are still vulnerable, with the aim of curing the disease."

Nell Barrie, Senior Science Information Manager at Cancer Research UK, said: "Better treatments for cancer have meant that today more than half of all patients with the disease survive. But many have to live with the uncertainty that their cancer could one day come back. This approach to rooting out that have hidden away and pre-emptively striking them is very promising and we now need to develop ways of doing this in patients."

Results of the study are published in Nature Medicine.

Explore further: Redirecting our immune cells to help fight children's cancer

More information: Kottke, T. Et al., "Tumor relapse can be detected and cured by targeting a phenotype of resistance to innate immune effectors during early recurrence." Nature Medicine (2013)

Related Stories

Redirecting our immune cells to help fight children's cancer

November 6, 2013
Immune cells, known as Natural Killer T cells, could be redirected to help fight the childhood cancer, neuroblastoma, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool ...

Some immune cells appear to aid cancer cell growth, study finds

September 5, 2013
The immune system is normally known for protecting the body from illness. But a subset of immune cells appear to be doing more harm than good.

Experimental drugs for breast cancer could treat lung cancer too

August 13, 2013
Cancer Research UK -funded scientists have discovered that experimental drugs first developed for breast and ovarian cancer could be used to treat the most common type of lung cancer, reveals research published in Oncogene ...

Double-pronged attack could treat common children's cancer

November 1, 2013
A dual-pronged strategy using two experimental cancer drugs together could successfully treat a childhood cancer by inhibiting tumour growth and blocking off the escape routes it uses to become resistant to treatment, finds ...

Potential brain tumour drug can distinguish cancer cells from healthy ones

October 31, 2013
A potential new drug, already in clinical development, can stop brain tumour cells growing while leaving healthy cells alone, according to new research published today (Wednesday) in PLOS ONE.

Blocking 'lock and key' site of lung cancer proteins could lead to new treatments

November 12, 2013
A Cancer Research UK study reveals that stopping two essential lung cancer proteins from joining together at their 'lock and key' site could lead to new treatments for the disease. The research is published in the journal ...

Recommended for you

Stem cell therapy attacks cancer by targeting unique tissue stiffness

July 26, 2017
A stem cell-based method created by University of California, Irvine scientists can selectively target and kill cancerous tissue while preventing some of the toxic side effects of chemotherapy by treating the disease in a ...

Understanding cell segregation mechanisms that help prevent cancer spread

July 26, 2017
Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.

Study uncovers potential 'silver bullet' for preventing and treating colon cancer

July 26, 2017
In preclinical experiments, researchers at VCU Massey Cancer Center have uncovered a new way in which colon cancer develops, as well as a potential "silver bullet" for preventing and treating it. The findings may extend to ...

Compound shows promise in treating melanoma

July 26, 2017
While past attempts to treat melanoma failed to meet expectations, an international team of researchers are hopeful that a compound they tested on both mice and on human cells in a petri dish takes a positive step toward ...

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.